Seed VC · Delemont, Switzerland
Skyviews Life Science identifies investment opportunities in companies at the growing interface between biotechnology, advanced nutrition and digital health, targeting private and public companies with better drugs, advanced technology platforms, preventive strategies, personalized solutions and more natural foods that improve people's quality of life.
Business models
biotech_therapeutics, platform, saas_b2b
Customer segments
Enterprise, Healthcare payors
We never publish partner emails directly — score your deck to unlock contacts for the firms ranked as best-fit.
Skyviews Life Science writes first institutional checks where the founder + early product matter more than traction. The seed market is the most dispersed segment of venture; matching to thesis (sector, stage, geography) is where most cold outreach succeeds or fails. VCboom tracks Skyviews Life Science alongside 47,000+ other active investors, ranked weekly by recent-deal momentum, sector concentration, and partner activity.
Family Office
Evli Growth Partners
insurtech, digital health, SaaS
Seed VC
TVM Capital Healthcare
healthcare, life sciences, medical devices
Family Office
Wholesale Investor
pharmaceuticals, medical devices, healthtech
Family Office
HB Biotechnology Ltd
biotechnology, medical technology
Seed VC
Granatus Ventures
artificial intelligence, advanced computing, data sciences
Seed VC
MTIP
healthcare technology, healthcare software, medical imaging
Drop your pitch. AI scores it on the 8 dimensions VCs read for and ranks the 47,000+ active investors in the database by fit. Skyviews Life Science is one of them — and we'll tell you exactly where they sit in your top 100.